Last mentioned: Mar 24, 2026
Phased Hiring
Recruitment for specialized engineering and scientific roles is expected to ramp up as construction nears completion.
Anticipated Groundbreaking
Expected commencement of construction for the multi-billion dollar manufacturing site.
Investment Announcement
UCB officially announces the $2 billion investment and 330-job creation plan for suburban Atlanta.
Belgian biopharma leader UCB has announced a massive $2 billion investment to construct a new manufacturing facility in suburban Atlanta, Georgia. The project is expected to create 330 high-tech jobs and significantly enhance the company's production capacity for its growing immunology and neurology portfolios.
Belgian biopharma giant UCB has announced a massive $2 billion investment to establish a new manufacturing plant in suburban Atlanta, creating 330 high-skilled jobs. The move strengthens UCB's U.S. footprint as it scales production for its high-growth immunology portfolio.
Belgian biopharmaceutical leader UCB has committed $2 billion to construct a new state-of-the-art manufacturing facility in suburban Atlanta, Georgia. The project is expected to create 330 high-skilled jobs and significantly bolster the region's growing life sciences ecosystem.
Belgian biopharma leader UCB is committing $2 billion to a new manufacturing facility in suburban Atlanta, creating 330 high-skilled positions. This investment underscores Georgia's rising status as a premier life sciences hub and highlights the intensifying competition for technical talent in the Southeast.